ArticleFrontiers in psychiatry2026
The effect of clinical and psychosocial factors on quality of life in COPD: a cross-sectional assessment using a mediation analysis approach.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond Spirometry: Dyspnea, Functional Limitation, and Psychological Distress Across GOLD Stages in COPD-A Multicenter Observational Study.Medicina (Kaunas, Lithuania) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to examine the relative contributions of clinical severity indicators and psychosocial factors-including depression, anxiety, stress, emotion regulation difficulties, and perceived social support-on quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD), and to test their mediating mechanisms within an integrated model. Methods: A total of 120 patients with COPD were assessed using spirometry, dyspnea, and symptom severity measures (mMRC, CAT), psychological assessments (DASS-21, DERS-16, MSPSS), and the WHOQOL-BREF. Mediation models using the PROCESS macro (Model 4) for SPSS were applied to evaluate the pathways linking clinical severity and psychosocial factors to quality-of-life domains. Results: Among 120 participants diagnosed with COPD, disease stages were found to be GOLD A: 25.8%, GOLD B: 35.8%, and GOLD E: 38.3%. Clinical severity measures (CAT, mMRC) were moderately correlated with both psychological symptoms and emotion-regulation difficulties (p < 0.05). CAT had a significant indirect adverse effect on physical quality of life via emotion regulation difficulties [b = -0.174, 95% CI (-0.303, -0.069)]. Perceived social support positively predicted physical quality of life via lower depressive symptoms (b = 0.52, 95% CI (0.06, 1.10)). Stress was indirectly associated with poorer psychological quality of life through reduced social support [b = -0.191, 95% CI (-0.363, -0.042)]. Conclusion: Psychosocial mechanisms substantially contribute to quality-of-life impairment in COPD and operate alongside traditional clinical indicators. Emotion-regulation difficulties and social support emerge as key psychological pathways linking symptom severity and quality-of-life outcomes, suggesting that comprehensive COPD management should integrate psychosocial intervention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.